These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4155636)

  • 41. Anxiolytic therapy. Oral and intravenous sedation.
    Henderson BN; Triplett RG; Gage TW
    Dent Clin North Am; 1994 Oct; 38(4):603-17. PubMed ID: 7805937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical relevance of pharmacokinetic differences in benzodiazepines].
    Weiershausen U
    Fortschr Med; 1981 Jun; 99(23):919-24. PubMed ID: 6114912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Studies on butylmalonic acidmono-(1,2-diphenylhydrazide)-calcium (bumadizone-calcium) labelled with 14C. Metabolism and kinetics].
    Ludwig G; Ache IM
    Arzneimittelforschung; 1973 Sep; 23(9):1226-31. PubMed ID: 4801214
    [No Abstract]   [Full Text] [Related]  

  • 44. Determination of alpidem and its metabolites in human plasma by high-performance liquid chromatography and fluorimetric detection.
    Ascalone V; Catalani P; Dal Bo' L; Deschamps N; Guinebault P
    J Chromatogr; 1987 Feb; 414(1):101-8. PubMed ID: 2883194
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Distribution of 14C-phenazepam and its metabolites in the liver, brain and blood plasma in single and prolonged administration to white rats].
    Golovenko NIa; Zin'kovskiĭ VG; Seredenin SB; Andronati SA; Iakubovskaia LN
    Farmakol Toksikol; 1980; 43(2):144-8. PubMed ID: 6108232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Concept of half-life and benzodiazepine metabolism. Critical study].
    Cano JP; Coassolo P
    Encephale; 1983; 9(4 Suppl 2):75B-80B. PubMed ID: 6144533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The pharmacokinetic characteristics of fenazepam in epileptics].
    Maksutova EL; Sariev AK; Zherdev VP; Voronina TA; Zheleznova EV
    Eksp Klin Farmakol; 1994; 57(2):16-8. PubMed ID: 7911365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of pharmacokinetics, brain levels and protein binding of centpropazine in rats.
    Bhattaram VA; Paliwal JK; Gupta RC
    Biopharm Drug Dispos; 2004 Mar; 25(2):69-75. PubMed ID: 14872554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The metabolism of indomethacin in man.
    Duggan DE; Hogans AF; Kwan KC; McMahon FG
    J Pharmacol Exp Ther; 1972 Jun; 181(3):563-75. PubMed ID: 4555898
    [No Abstract]   [Full Text] [Related]  

  • 50. Metabolic fate of the anti-inflammatory agent alpha-(4-(1-oxo-2-isoindolinyl)-phenyl)-propionic acid (K 4277) in the rhesus monkey.
    Chasseaud LF; Fry BJ; Valzelli G; Tosolini GP
    Arzneimittelforschung; 1974 Oct; 24(10):1606-9. PubMed ID: 4479769
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
    Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
    Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kinetics and metabolism of clobazam in animals and man.
    Volz M; Christ O; Kellner HM; Kuch H; Fehlhaber HW; Gantz D; Hajdu P; Cavagna F
    Br J Clin Pharmacol; 1979; 7 Suppl 1(Suppl 1):41S-50S. PubMed ID: 35204
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacokinetic aspects of habituation to benzodiazepines.
    Chodera A; Szczawińska K; Cenajek D; Nowakowska E
    Pol J Pharmacol Pharm; 1984; 36(4):353-60. PubMed ID: 6152051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Significance of pharmacokinetic findings for the clinical effect of benzodiazepines].
    Horowski R; Dorow R
    Internist (Berl); 1982 Nov; 23(11):632-40. PubMed ID: 6130052
    [No Abstract]   [Full Text] [Related]  

  • 55. Pharmacokinetic profile of sulfisoxazole following intravenous, intramuscular, and oral administration to man.
    Kaplan SA; Weinfeld RE; Abruzzo CW; Lewis M
    J Pharm Sci; 1972 May; 61(5):773-8. PubMed ID: 5035788
    [No Abstract]   [Full Text] [Related]  

  • 56. [Kinetics and metabolite patterns of urapidil in humans].
    Kukovetz WR; Ludwig G; Vergin H; Zech K; Steinijans V; Bruckschen EG
    Arzneimittelforschung; 1977; 27(12):2406-11. PubMed ID: 580057
    [No Abstract]   [Full Text] [Related]  

  • 57. Plasma concentrations in the monkey (Macaca mulatta) of six related benzodiazepines after intraperitoneal injection [proceedings].
    Curry SH; Nicholson AN; Whelpton R
    Br J Pharmacol; 1976 Jul; 57(3):427P-428P. PubMed ID: 10030
    [No Abstract]   [Full Text] [Related]  

  • 58. Sublingual use of benzodiazepines.
    Calis KA; Mitsch RA
    Drug Intell Clin Pharm; 1985 Nov; 19(11):839-40. PubMed ID: 2866080
    [No Abstract]   [Full Text] [Related]  

  • 59. The metabolism of bromazepam in the rat--identification of mercapturic acid and its conversion in vitro to methylthio-bromazepam.
    Tateishi M; Suzuki S; Shimizu H
    Biochem Pharmacol; 1978 Mar; 27(5):809-10. PubMed ID: 26351
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacokinetic aspects of anxiolytic drug therapy.
    Greenblatt DJ; Shader RI
    Can J Neurol Sci; 1980 Aug; 7(3):269-70. PubMed ID: 6108797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.